Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer
Clinical trial NCT04177810 · COMPLETED
Trial details
- NCT number
- NCT04177810
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-16
- Primary completion
- 2023-03-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.